By vgreene, 11 March, 2021 Study considerations meta analysis incl 4 observational studies quality of evidence low publication bias due to small sample size
By vgreene, 11 March, 2021 KEY FINDINGS reduced all cause mortality and significant clinical improvement w add on ivermectin tx
By vgreene, 11 March, 2021 Therapeutic Potential of Ivermectin as Add On Treatment in COVID 19 A Systematic Review and Meta analysis
By vgreene, 11 March, 2021 Study considerations multihospital retrospective cohort study N 280 possible timing bias as more of the control group enrolled in 1st weeks of study pts also received other tx incl HCQ AZ or both
By vgreene, 11 March, 2021 KEY FINDINGS ivermectin tx associated w lower mortality esp in pts w severe pulmonary involvement
By vgreene, 11 March, 2021 Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019
By vgreene, 11 March, 2021 Study considerations double blind RCT small sample size N 72 early viral clearance not shown in ivermectin doxycycline group
